Vascular malformations are birth defects that happen when different stages of angiogenesis shut down. 44 - 64% of all vascular malformations are venous malformations (VMs). Sclerotherapy is the first treatment line for VMs. It acts by getting rid of the vascular endothelial cells in the lesion. One of the most common and well researched sclerosing agents for VMs is polidocanol, which is a popular counterpart for concentrated ethanol.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
20
Ethanol is an organic compound that will be injected in the venous malformation as a sclerotherapy by Direct Puncture Repair
Polidocanol is a sclerosing agent that will be injected in the venous malformation by Direct Puncture Repair
Walied Khereba
Zagazig, Egypt
Heaviness questionnaire
Heaviness of the affected part may be unchanged, or decreased or disppeared, or relapsed
Time frame: 6 months post operative
Disfigurement questionnaire
Disfigurementof the affected part may be unchanged, or decreased or disppeared, or relapsed
Time frame: 6 months post operative
size of venous malformation
it assess the size of malformations after injection; which may be unchanged, or decreased or disppeared, or relapsed
Time frame: 6 months post operative
Degree of satisfaction
It may be; Very satisfied, or satisfied, or not satisfied, or Dissatisfied.
Time frame: 6 months post operative
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.